Infectious Diseases Newsletter

The new “prime” and “spike” approach may help prevent breakthrough infections of vaccinated individuals by bolstering immune response within the mucosal lining of the respiratory tract, which are the first cells attacked by COVID-19.

In March 2020, Maricar Malinis, MD, FACP, FIDSA, FAST, and a group of colleagues were called to an emergency meeting. COVID-19 was on the horizon, and no one knew what to expect. The anxiety was palpable. The date itself was inauspicious: Friday the 13th.

Discoveries & Impact highlights select scientific discoveries for each of the 11 section in the Department of Internal Medicine.

Sandra Springer received the Avant-Garde Award from the National Institute on Drug Abuse. Her research plan is inspired by the U.S. Department of Health and Human Service’s Ending the HIV Epidemic in the U.S. (EHE) initiative, which aims to scale up key HIV prevention and treatment strategies with the goal of reducing new HIV infections by 90% by 2030.

Discoveries & Impact highlights select scientific discoveries per section across Yale's Department of Internal Medicine...

Fifteen staff members within the Department of Internal Medicine are celebrating huge milestones in 2022: 20, 25, 30, and 40 years working at Yale University.

Barbara Kazmierczak, MD, PhD, Gustavus and Louise Pfeiffer Research Foundation MD/PhD Program Director and Professor of Medicine (Infectious Diseases) and of Microbial Pathogenesis; and director, MD/PhD Program, has been named vice chair, Basic Research, for the Department of Internal Medicine, effective immediately.

The development of a vaccine for leptospirosis would have huge implications for global public health, said senior author Joseph Vinetz, MD, with the greatest impact being in developing countries where there is a high disease burden that is completely unmet.

Dennis Shung, MD, MHS, PhD, and Benjamin Goldman-Israelow, MD, PhD, are celebrated as the 2022 Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award honorees.